Pfizer Inc. (PFE)

USD 25.89

(-2.04%)

Gross Profit Summary of Pfizer Inc.

  • Pfizer Inc.'s latest annual gross profit in 2023 was 28.8 Billion USD , down -55.62% from previous year.
  • Pfizer Inc.'s latest quarterly gross profit in 2024 Q3 was 12.43 Billion USD , up 34.99% from previous quarter.
  • Pfizer Inc. reported a annual gross profit of 65.98 Billion USD in annual gross profit 2022, up 30.75% from previous year.
  • Pfizer Inc. reported a annual gross profit of 50.46 Billion USD in annual gross profit 2021, up 51.94% from previous year.
  • Pfizer Inc. reported a quarterly gross profit of 8.24 Billion USD for 2024 Q2, down -21.48% from previous quarter.
  • Pfizer Inc. reported a quarterly gross profit of 12.43 Billion USD for 2024 Q3, up 34.99% from previous quarter.

Annual Gross Profit Chart of Pfizer Inc. (2023 - 1989)

Historical Annual Gross Profit of Pfizer Inc. (2023 - 1989)

Year Gross Profit Gross Profit Growth
2023 28.8 Billion USD -55.62%
2022 65.98 Billion USD 30.75%
2021 50.46 Billion USD 51.94%
2020 33.21 Billion USD -20.02%
2019 41.53 Billion USD -2.05%
2018 42.39 Billion USD 2.65%
2017 41.3 Billion USD 2.0%
2016 40.49 Billion USD 3.3%
2015 39.2 Billion USD -2.06%
2014 40.02 Billion USD -4.69%
2013 41.99 Billion USD -11.87%
2012 47.65 Billion USD -8.96%
2011 52.34 Billion USD 1.57%
2010 51.53 Billion USD 25.31%
2009 41.12 Billion USD 2.33%
2008 40.18 Billion USD 8.08%
2007 37.17 Billion USD -8.72%
2006 40.73 Billion USD -4.77%
2005 42.77 Billion USD -4.9%
2004 44.97 Billion USD 27.21%
2003 35.35 Billion USD 24.81%
2002 28.32 Billion USD 4.05%
2001 27.22 Billion USD 6.7%
2000 25.51 Billion USD 79.46%
1999 14.21 Billion USD 19.09%
1998 11.93 Billion USD 11.25%
1997 10.73 Billion USD 12.26%
1996 9.56 Billion USD 16.14%
1995 8.23 Billion USD 23.69%
1994 6.65 Billion USD 11.58%
1993 5.96 Billion USD 9.03%
1992 5.46 Billion USD 9.54%
1991 4.99 Billion USD 14.23%
1990 4.37 Billion USD 14.55%
1989 3.81 Billion USD 7.21%

Peer Gross Profit Comparison of Pfizer Inc.

Name Gross Profit Gross Profit Difference
AbbVie Inc. 45.53 Billion USD 36.736%
Bristol-Myers Squibb Company 34.31 Billion USD 16.041%
Bristol-Myers Squibb Company Ce 34.31 Billion USD 16.041%
Johnson & Johnson 58.6 Billion USD 50.843%
Eli Lilly and Company 27.04 Billion USD -6.535%
Merck & Co., Inc. 43.98 Billion USD 34.509%
Novartis AG 34.18 Billion USD 15.734%
Organon & Co. 3.74 Billion USD -668.65%